A High Court judge has refused Paddy Digan’s application for summary judgment against the founder of now-defunct Pharmapod over a contentious loan. The dispute sheds light on the circumstances surrounding the company's demise.
John Power's Aerogen is transitioning to the world of biopharmaceutics. The Galway entrepreneur talks about securing backing from the Gates Foundation, and the prospect of raising more funds later this year.
The start-up, formed just this year, is building a device for treating internal bleeding and tumours and Elkstone and Atlantic Bridge have now backed it.
The Dublin-based company makes glue for closing wounds and has been acquired as part of a broader €180 million deal.
The Galway medtech start-up is preparing trials for its device for diabetics in the US and is planning a funding round in the coming months.
The Waterford medtech company has brought on a new investor in US firm Five Arrows and is eyeing a major R&D and manufacturing expansion stateside.
Despite a dangerously low share price, the Bray company has remained acquisitive, buying up companies that have brought it into new verticals.
Imelda Lambkin heads up the Disruptive Technologies Innovation Fund, tasked with backing cutting-edge tech projects in Ireland. She talks to The Currency about the fund’s mission and its future.
The US-listed company, which owns a medical device plant in Galway, moved its incorporation – and tax residence – from Switzerland to Ireland this week.
The deal sees the Stockholm-listed animal health group acquire the Meath-based company for an initial €84m with a further €60m dependent on targets.
© 2025 Currency Media Limited
